BIOLIPOX AB has a total of 225 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are NEUROPHARMA SA, MELACURE THERAPEUTICS AB and ALCARAZ LILIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 45 | |
#2 | EPO (European Patent Office) | 37 | |
#3 | Canada | 28 | |
#4 | China | 17 | |
#5 | United Kingdom | 11 | |
#6 | Argentina | 10 | |
#7 | Taiwan | 10 | |
#8 | United States | 10 | |
#9 | Brazil | 8 | |
#10 | Australia | 7 | |
#11 | Republic of Korea | 7 | |
#12 | Israel | 6 | |
#13 | Mexico | 6 | |
#14 | Sweden | 6 | |
#15 | South Africa | 5 | |
#16 | Norway | 4 | |
#17 | New Zealand | 3 | |
#18 | Hong Kong | 2 | |
#19 | EAPO (Eurasian Patent Organization) | 1 | |
#20 | Montenegro | 1 | |
#21 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology | |
#5 | Measurement | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Unspecified technologies | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes | |
#8 | Peptides | |
#9 | Enzymes | |
#10 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Pelcman Benjamin | 144 |
#2 | Katkevics Martins | 77 |
#3 | Nilsson Peter | 70 |
#4 | Olofsson Kristofer | 63 |
#5 | Kalvins Ivars | 55 |
#6 | Suna Edgars | 55 |
#7 | Ozola Vita | 52 |
#8 | Sanin Andrei | 40 |
#9 | Schaal Wesley | 39 |
#10 | Kromann Hasse | 28 |
Publication | Filing date | Title |
---|---|---|
GB201507753D0 | New compounds and uses | |
GB201507752D0 | New compounds and uses | |
GB201407596D0 | New compounds and uses | |
GB201407599D0 | New compounds and uses | |
GB201307202D0 | New compounds and uses | |
GB201307201D0 | New compounds and uses | |
GB201207075D0 | New compounds and uses | |
GB201206998D0 | New compound and uses | |
GB201206973D0 | New compounds and uses | |
WO2011114103A1 | Pyrimidinones for use as medicaments | |
EP2545036A1 | Bis aromatic compounds for use as ltc4 synthase inhibitors | |
EP2406223A2 | Bis aromatic compounds for use as ltc4 synthase inhibitors | |
CA2754936A1 | Bis aromatic compounds for use as ltc4 synthase inhibitors | |
EP2406219A1 | Bis aromatic compounds for use as ltc4 synthase inhibitors | |
WO2010103283A1 | Bis aromatic compounds for use as ltc4 synthase inhibitors | |
WO2010076564A2 | Isochromenones useful in the treatment of inflammation | |
WO2010076566A2 | Indoles useful in the treatment of inflammation | |
CA2736970A1 | Pyrimidinone derivatives for use as medicaments | |
CA2698847A1 | Bis-aromatic compounds useful in the treatment of inflammation | |
WO2008135767A1 | New triazole compounds useful in the treatment of inflammation |